Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral etoposide maintenance in extensive-stage small cell lung cancer
ChiCTR-TRC-13003585Phase 3Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of etoposide in small cell lung cancer (SCLC) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Progression-free survival and Overall survival. Started Jan 2014; status: completed.
02
Drugs
etoposide
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on ChiCTR-TRC-13003585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003585.